[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2027 Global Intravenous Iron Drug Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

April 2020 | 116 pages | ID: 27846A2AA4D2EN
Maia Research

US$ 3,460.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The worldwide market for Intravenous Iron Drug is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Daiichi Sankyo, Inc.
Sanofi US
Allergan Plc
AMAG Pharmaceuticals, Inc.
Pharmacosmos A/S
Luitpold Pharmaceuticals, Inc.

Major Types Covered
Ferric carboxymaltose
Iron Sucrose
Iron Dextran
Others

Major Applications Covered
Nephrology
Gynecology & Obstetrics
Gastroenterology
Oncology
Cardiology
Others

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Intravenous Iron Drug Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Intravenous Iron Drug Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE INTRAVENOUS IRON DRUG MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL INTRAVENOUS IRON DRUG MARKET-SEGMENTATION BY TYPE

5.1 Ferric carboxymaltose
5.2 Iron Sucrose
5.3 Iron Dextran
5.4 Others

6 GLOBAL INTRAVENOUS IRON DRUG MARKET-SEGMENTATION BY APPLICATION

6.1 Nephrology
6.2 Gynecology & Obstetrics
6.3 Gastroenterology
6.4 Oncology
6.5 Cardiology
6.6 Others

7 GLOBAL INTRAVENOUS IRON DRUG MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Daiichi Sankyo, Inc.
  8.1.1 Daiichi Sankyo, Inc. Profile
  8.1.2 Daiichi Sankyo, Inc. Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Daiichi Sankyo, Inc. Product/Solution Launches and Enhancements Analysis
  8.1.4 Daiichi Sankyo, Inc. Business Overview/Recent Development/Acquisitions
8.2 Sanofi US
  8.2.1 Sanofi US Profile
  8.2.2 Sanofi US Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Sanofi US Product/Solution Launches and Enhancements Analysis
  8.2.4 Sanofi US Business Overview/Recent Development/Acquisitions
8.3 Allergan Plc
  8.3.1 Allergan Plc Profile
  8.3.2 Allergan Plc Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Allergan Plc Product/Solution Launches and Enhancements Analysis
  8.3.4 Allergan Plc Business Overview/Recent Development/Acquisitions
8.4 AMAG Pharmaceuticals, Inc.
  8.4.1 AMAG Pharmaceuticals, Inc. Profile
  8.4.2 AMAG Pharmaceuticals, Inc. Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 AMAG Pharmaceuticals, Inc. Product/Solution Launches and Enhancements Analysis
  8.4.4 AMAG Pharmaceuticals, Inc. Business Overview/Recent Development/Acquisitions
8.5 Pharmacosmos A/S
  8.5.1 Pharmacosmos A/S Profile
  8.5.2 Pharmacosmos A/S Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Pharmacosmos A/S Product/Solution Launches and Enhancements Analysis
  8.5.4 Pharmacosmos A/S Business Overview/Recent Development/Acquisitions
8.6 Luitpold Pharmaceuticals, Inc.
  8.6.1 Luitpold Pharmaceuticals, Inc. Profile
  8.6.2 Luitpold Pharmaceuticals, Inc. Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Luitpold Pharmaceuticals, Inc. Product/Solution Launches and Enhancements Analysis
  8.6.4 Luitpold Pharmaceuticals, Inc. Business Overview/Recent Development/Acquisitions

9 GLOBAL INTRAVENOUS IRON DRUG MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Intravenous Iron Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Intravenous Iron Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Intravenous Iron Drug Production Analysis from 2015-2020
10.4 North America Intravenous Iron Drug Consumption Analysis from 2015-2020
10.5 North America Intravenous Iron Drug Import and Export from 2015-2020
10.6 North America Intravenous Iron Drug Value, Production and Market Share by Type (2015-2020)
10.7 North America Intravenous Iron Drug Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Intravenous Iron Drug by Country (United States, Canada)
  10.8.1 North America Intravenous Iron Drug Sales by Country (2015-2020)
  10.8.2 North America Intravenous Iron Drug Consumption Value by Country (2015-2020)
10.9 North America Intravenous Iron Drug Market PEST Analysis

11 EUROPE

11.1 Europe Intravenous Iron Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Intravenous Iron Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Intravenous Iron Drug Production Analysis from 2015-2020
11.4 Europe Intravenous Iron Drug Consumption Analysis from 2015-2020
11.5 Europe Intravenous Iron Drug Import and Export from 2015-2020
11.6 Europe Intravenous Iron Drug Value, Production and Market Share by Type (2015-2020)
11.7 Europe Intravenous Iron Drug Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Intravenous Iron Drug by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Intravenous Iron Drug Sales by Country (2015-2020)
  11.8.2 Europe Intravenous Iron Drug Consumption Value by Country (2015-2020)
11.9 Europe Intravenous Iron Drug Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Intravenous Iron Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Intravenous Iron Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Intravenous Iron Drug Production Analysis from 2015-2020
12.4 Asia-Pacific Intravenous Iron Drug Consumption Analysis from 2015-2020
12.5 Asia-Pacific Intravenous Iron Drug Import and Export from 2015-2020
12.6 Asia-Pacific Intravenous Iron Drug Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Intravenous Iron Drug Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Intravenous Iron Drug by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Intravenous Iron Drug Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Intravenous Iron Drug Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Intravenous Iron Drug Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Intravenous Iron Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Intravenous Iron Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Intravenous Iron Drug Production Analysis from 2015-2020
13.4 Latin America Intravenous Iron Drug Consumption Analysis from 2015-2020
13.5 Latin America Intravenous Iron Drug Import and Export from 2015-2020
13.6 Latin America Intravenous Iron Drug Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Intravenous Iron Drug Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Intravenous Iron Drug by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Intravenous Iron Drug Sales by Country (2015-2020)
  13.8.2 Latin America Intravenous Iron Drug Consumption Value by Country (2015-2020)
13.9 Latin America Intravenous Iron Drug Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Intravenous Iron Drug Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Intravenous Iron Drug Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Intravenous Iron Drug Production Analysis from 2015-2020
14.4 Middle East & Africa Intravenous Iron Drug Consumption Analysis from 2015-2020
14.5 Middle East & Africa Intravenous Iron Drug Import and Export from 2015-2020
14.6 Middle East & Africa Intravenous Iron Drug Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Intravenous Iron Drug Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Intravenous Iron Drug by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Intravenous Iron Drug Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Intravenous Iron Drug Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Intravenous Iron Drug Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL INTRAVENOUS IRON DRUG MARKET FROM 2020-2027

15.1 Future Forecast of the Global Intravenous Iron Drug Market from 2020-2027 Segment by Region
15.2 Global Intravenous Iron Drug Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Intravenous Iron Drug Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

LIST OF TABLES AND FIGURES

Global Intravenous Iron Drug Market Value ($) and Growth Rate of Intravenous Iron Drug from 2015-2027
Global Intravenous Iron Drug Production and Growth Rate Segment by Product Type from 2015-2027
Global Intravenous Iron Drug Consumption and Growth Rate Segment by Application from 2015-2027
Figure Intravenous Iron Drug Picture
Table Product Specifications of Intravenous Iron Drug
Table Driving Factors for this Market
Table Industry News of Intravenous Iron Drug Market
Figure Value Chain Status of Intravenous Iron Drug
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Intravenous Iron Drug Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Intravenous Iron Drug Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Ferric carboxymaltose of Intravenous Iron Drug
Figure Iron Sucrose of Intravenous Iron Drug
Figure Iron Dextran of Intravenous Iron Drug
Figure Others of Intravenous Iron Drug
Table Global Intravenous Iron Drug Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Intravenous Iron Drug Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Nephrology of Intravenous Iron Drug
Figure Gynecology & Obstetrics of Intravenous Iron Drug
Figure Gastroenterology of Intravenous Iron Drug
Figure Oncology of Intravenous Iron Drug
Figure Cardiology of Intravenous Iron Drug
Figure Others of Intravenous Iron Drug
Table Global Intravenous Iron Drug Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Intravenous Iron Drug Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Intravenous Iron Drug
Figure Online Channel of Intravenous Iron Drug
Table Daiichi Sankyo, Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Daiichi Sankyo, Inc. Sales and Growth Rate from 2015-2020
Figure Daiichi Sankyo, Inc. Revenue ($) and Global Market Share from 2015-2020
Table Daiichi Sankyo, Inc. Intravenous Iron Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sanofi US Profile (Company Name, Plants Distribution, Sales Region)
Figure Sanofi US Sales and Growth Rate from 2015-2020
Figure Sanofi US Revenue ($) and Global Market Share from 2015-2020
Table Sanofi US Intravenous Iron Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Allergan Plc Profile (Company Name, Plants Distribution, Sales Region)
Figure Allergan Plc Sales and Growth Rate from 2015-2020
Figure Allergan Plc Revenue ($) and Global Market Share from 2015-2020
Table Allergan Plc Intravenous Iron Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table AMAG Pharmaceuticals, Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure AMAG Pharmaceuticals, Inc. Sales and Growth Rate from 2015-2020
Figure AMAG Pharmaceuticals, Inc. Revenue ($) and Global Market Share from 2015-2020
Table AMAG Pharmaceuticals, Inc. Intravenous Iron Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pharmacosmos A/S Profile (Company Name, Plants Distribution, Sales Region)
Figure Pharmacosmos A/S Sales and Growth Rate from 2015-2020
Figure Pharmacosmos A/S Revenue ($) and Global Market Share from 2015-2020
Table Pharmacosmos A/S Intravenous Iron Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Luitpold Pharmaceuticals, Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Luitpold Pharmaceuticals, Inc. Sales and Growth Rate from 2015-2020
Figure Luitpold Pharmaceuticals, Inc. Revenue ($) and Global Market Share from 2015-2020
Table Luitpold Pharmaceuticals, Inc. Intravenous Iron Drug Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Intravenous Iron Drug Production Value ($) by Region from 2015-2020
Table Global Intravenous Iron Drug Production Value Share by Region from 2015-2020
Table Global Intravenous Iron Drug Production by Region from 2015-2020
Table Global Intravenous Iron Drug Consumption Value ($) by Region from 2015-2020
Table Global Intravenous Iron Drug Consumption by Region from 2015-2020
Table North America Intravenous Iron Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Intravenous Iron Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Intravenous Iron Drug Import and Export from 2015-2020
Table North America Intravenous Iron Drug Value ($) by Type (2015-2020)
Table North America Intravenous Iron Drug Production by Type (2015-2020)
Table North America Intravenous Iron Drug Consumption by Application (2015-2020)
Table North America Intravenous Iron Drug Consumption by Country (2015-2020)
Table North America Intravenous Iron Drug Consumption Value ($) by Country (2015-2020)
Figure North America Intravenous Iron Drug Market PEST Analysis
Table Europe Intravenous Iron Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Intravenous Iron Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Intravenous Iron Drug Import and Export from 2015-2020
Table Europe Intravenous Iron Drug Value ($) by Type (2015-2020)
Table Europe Intravenous Iron Drug Production by Type (2015-2020)
Table Europe Intravenous Iron Drug Consumption by Application (2015-2020)
Table Europe Intravenous Iron Drug Consumption by Country (2015-2020)
Table Europe Intravenous Iron Drug Consumption Value ($) by Country (2015-2020)
Figure Europe Intravenous Iron Drug Market PEST Analysis
Table Asia-Pacific Intravenous Iron Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Intravenous Iron Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Intravenous Iron Drug Import and Export from 2015-2020
Table Asia-Pacific Intravenous Iron Drug Value ($) by Type (2015-2020)
Table Asia-Pacific Intravenous Iron Drug Production by Type (2015-2020)
Table Asia-Pacific Intravenous Iron Drug Consumption by Application (2015-2020)
Table Asia-Pacific Intravenous Iron Drug Consumption by Country (2015-2020)
Table Asia-Pacific Intravenous Iron Drug Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Intravenous Iron Drug Market PEST Analysis
Table Latin America Intravenous Iron Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Intravenous Iron Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Intravenous Iron Drug Import and Export from 2015-2020
Table Latin America Intravenous Iron Drug Value ($) by Type (2015-2020)
Table Latin America Intravenous Iron Drug Production by Type (2015-2020)
Table Latin America Intravenous Iron Drug Consumption by Application (2015-2020)
Table Latin America Intravenous Iron Drug Consumption by Country (2015-2020)
Table Latin America Intravenous Iron Drug Consumption Value ($) by Country (2015-2020)
Figure Latin America Intravenous Iron Drug Market PEST Analysis
Table Middle East & Africa Intravenous Iron Drug Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Intravenous Iron Drug Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Intravenous Iron Drug Import and Export from 2015-2020
Table Middle East & Africa Intravenous Iron Drug Value ($) by Type (2015-2020)
Table Middle East & Africa Intravenous Iron Drug Production by Type (2015-2020)
Table Middle East & Africa Intravenous Iron Drug Consumption by Application (2015-2020)
Table Middle East & Africa Intravenous Iron Drug Consumption by Country (2015-2020)
Table Middle East & Africa Intravenous Iron Drug Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Intravenous Iron Drug Market PEST Analysis
Table Global Intravenous Iron Drug Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Intravenous Iron Drug Production and Growth Rate Forecast by Region (2020-2027)
Table Global Intravenous Iron Drug Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Intravenous Iron Drug Production and Growth Rate Forecast by Type (2020-2027)
Table Global Intravenous Iron Drug Consumption and Growth Rate Forecast by Application (2020-2027)


More Publications